Soerensen, A.V. et al. 2016. A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2. Acta Oncologica. 55, 3 (Mar. 2016), 341–348. DOI:https://doi.org/10.3109/0284186X.2015.1091499.